MIMOSA Diagnostics

MIMOSA Diagnostics

Private
TorontoHealthcare & Life Scienceshttps://mimosadiagnostics.com

Last Round

VC Round

Jun 10, 2024

Total Funding Raised

$168,000

Momentum Score

25 /100

Company Overview

MIMOSA Diagnostics is a medical device company that has developed a handheld, multispectral skin tissue imaging device and data platform for early and accurate diagnosis of a wide range of skin tissue injuries.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Medical Imaging, Telemedicine, Health IoT

Business Model

B2B

Customer Profile

Hardware + Subscription, Services & Consulting

AI Layer

Application

Keywords

non-invasive imagingtissue health assessmentportable imagingpoint-of-care diagnosticswound care technologymedical imaging devicetissue oxygenationremote patient monitoringdiabetic foot ulcerpressure injuryHardware-as-a-ServiceHaaSMedTechnear-infrared imaginghandheld medical deviceHIPAA compliance

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

MIMOSA Diagnostics Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

MIMOSA Diagnostics Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
VC RoundJun 10, 2024
GrantMar 27, 2024
Convertible DebtJul 17, 2023
GrantDec 20, 2020
SeedMay 6, 2020
Grant
Apr 1, 2020

Key People

Founding team and executive leadership

Karen Cross

Co-Founder And CEO

Founding Team

Paul Weber

Advisor To The CEO Founder

Founding Team

Kevin Weitzman

Chief Financial Officer, Board Member

Executive Team

MIMOSA Diagnostics Investors

Notable investors and investment history

MIMOSA Diagnostics Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

MIMOSA Diagnostics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about MIMOSA Diagnostics's valuation, stock price, and market status.

Firmographic Details

HeadquartersToronto
Employee Range35
Year Founded2016
Last FundingJun 10, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.